The goal of this clinical trial is to learn whether Waltz dance can improve cardiometabolic and bone health in sedentary women aged 45-65 with abnormal lipid levels. The main questions it aims to answer are:
Can Waltz dance improve blood lipid profiles, including total cholesterol, triglycerides, HDL-C, and LDL-C? Can it improve body composition, cardiorespiratory fitness, vascular function, and bone mineral density? Researchers will compare a Waltz dance group with a control group that maintains their usual lifestyle to see if the dance intervention leads to better health outcomes.
Participants will:
Attend supervised Waltz dance classes three times a week for 12 weeks, each session lasting 105 minutes.
Complete physical tests and blood draws before and after the program to measure changes in lipid levels, body composition, fitness, and bone density.
Wear an accelerometer to monitor energy expenditure and physical activity during the program.
Female participants aged between 45 and 65 years.
Diagnosed with dyslipidemia (based on clinical lipid profile: TC ≥ 6.2 mmol/L, TG ≥ 2.3 mmol/L, LDL-C ≥ 4.1 mmol/L, or HDL-C < 1.0 mmol/L).
Sedentary lifestyle (less than 60 minutes of structured physical activity per week in the last 6 months).
Able to participate safely in moderate-intensity exercise as confirmed by a medical evaluation.
Diagnosis of cardiovascular disease requiring medical supervision during exercise (e.g., unstable angina, recent myocardial infarction).
Severe musculoskeletal disorders (e.g., advanced osteoarthritis, recent fractures) limiting mobility or physical activity.
Neurological or cognitive disorders affecting motor function or communication.
Uncontrolled hypertension (SBP ≥ 160 mmHg or DBP ≥ 100 mmHg at rest).